FHECX
Price
$17.71
Change
-$0.08 (-0.45%)
Updated
Sep 20 closing price
VGSIX
Price
$32.50
Change
-$0.12 (-0.37%)
Updated
Sep 20 closing price
Ad is loading...

FHECX vs VGSIX

Header iconFHECX vs VGSIX Comparison
Open Charts FHECX vs VGSIXBanner chart's image
Fidelity Advisor Real Estate C
Price$17.71
Change-$0.08 (-0.45%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Investor
Price$32.50
Change-$0.12 (-0.37%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FHECX vs VGSIX Comparison Chart
Loading...
VS
FHECX vs. VGSIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHECX is a StrongSell and VGSIX is a StrongSell.

FUNDAMENTALS
Fundamentals
VGSIX has more cash in the bank: 70.5B vs. FHECX (245M). VGSIX pays higher dividends than FHECX: VGSIX (3.85) vs FHECX (1.50). FHECX was incepted earlier than VGSIX: FHECX (22 years) vs VGSIX (28 years). FHECX is a more actively managed with annual turnover of: 31.00 vs. VGSIX (9.00). FHECX has a lower initial minimum investment than VGSIX: FHECX (0) vs VGSIX (3000). VGSIX (30.65) and FHECX (29.37) have marching annual gain over last year. VGSIX return over 5 years is better than : 25.45 vs. FHECX (-19.55).
FHECXVGSIXFHECX / VGSIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years28 years-
Gain YTD12.14912.97994%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets245M70.5B0%
Annual Yield % from dividends1.503.8539%
Returns for 1 year29.3730.6596%
Returns for 3 years-22.683.36-674%
Returns for 5 years-19.5525.45-77%
Returns for 10 years-3.9586.34-5%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SIDU2.750.09
+3.38%
Sidus Space
TUSK3.920.09
+2.35%
Mammoth Energy Services
ADNT22.670.08
+0.35%
Adient plc
NICE164.89-0.94
-0.57%
NICE Ltd
PLRX12.15-0.47
-3.72%
Pliant Therapeutics